The limitations of antiepileptic drug monotherapy

Epilepsia

Volumn 38, Issue SUPPL. 5, 1997, Pages

  Kramer G ^a  

^a SWISS EPILEPSY CENTER   (Switzerland)

Author keywords

Anticonvulsants; Drug interactions; Drug monitoring; Drug toxicity

Indexed keywords

EID: 0001807484     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1997.tb04599.x     Document Type: Article

References (21)

1. Theodore WH, Porter RJ. Epilepsy. 100 elementary principles. 3rd ed. Philadelphia: Saunders, 1995:74.
2. Lammers MW, Hekster YA, Keyser A, Meinardi H, Reiner WO, Herings RM. Use of antiepileptic drugs in a community-dwelling Dutch population. Neurology 1996;46:62-7.
3. Covanis A, Gupta AK, Jeavons PM. Sodium valproate: monotherapy and polytherapy. Epilepsia 1982;23:693-720.
4. Dulac O, Stern D, Rey E, Arthuis M. Sodium valproate monotherapy in childhood epilepsy. Brain Dev 1986;8:47-52.
5. Heller AJ, Chesterman P, Elwes RDC, et al. Comparative efficacy and toxicity of phenobarbital, phenytoin, carbamazepine, and valproate in adults and randomized long-term trial. J Neural Neurosurg Psychiatry 1995;58:44-50.
6. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985; 313:145-51.
7. Matlson RH, Cramer JA, Collins JF, and The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 1992;327:765-71.
8. Perucca E. Principles of drug treatment. In: Shorvon S, Dreifuss F, Fish D, Thomas D, eds. The treatment of epilepsies. Oxford: Blackwell Science, 1996:152-68.
9. Richens A, Davidson DLW, Cartlidge NEF, Easter DJ, on behalf of the Adult EPITEG Collaborative Group. A multicentre collaborative trial of sodium valproate and carbamazepine in adult onset epilepsy. J Neural Neurosurg Psychiatry 1994:57:682-7.
10. Shorvon SD, Chadwick D, Galbraith AW, Reynolds EH. One drug for epilepsy. BMJ 1978:1:474-6.
11. Dean JC, Penry JK. Carbamazepine/valproate therapy in 100 patients with partial seizures failing carbamazepine monotherapy: long-term follow-up. Epilepsia 1988:29:687.
12. Hakkarainen H. Carbamazepine vs diphenylhydantoin vs their combination in adult epilepsy. Neurology 1980;30:354.
13. Walker JE, Koon P. Carbamazepine versus valproate versus combined therapy for refractory partial complex seizures with secondary generalization. Epilepsia 1988:29:693.
14. Willmore LJ, Shu V, Wallin B, and the M88-194 Study Group. Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures. Neurology 1996:46:49-53.
15. Bourgeois BFD, Wad N. Combined administration of Carbamazepine and phenobarbital: effect on anticonvulsant activity and neurotoxicity. Epilepsia 1988:29:482-7.
16. Duncan JS. Principles of treatment of patients with chronic active epilepsy. In: Shorvon S. Dreifuss F, Fish D. Thomas D, eds. The treatment of epilepsies. Oxford: Blackwell Science, 1996:177-90.
17. Ferendelli JA. Rational polypharmacy. Epilepsia 1995;36(suppl 2):S115-8.
18. Rowan AJ, Meijer JWA, de Beer-Pawlikowski N, van der Geest P. Valproate ethosoximide combination therapy for refractory absence seizures. Arch Neural 1983:40:797-802.
19. Hart YM. Principles of treatment of newly diagnosed patients. In: Shorvon S, Dreifuss F, Fish D, Thomas D. eds. The treatment of epilepsies. Oxford: Blackwell Science. 1996:169-76.
20. Schmidt D. Gram L. Monotherapy versus polytherapy in epilepsy. A reappraisal. CNS Drugs 1995:3:194-208.
21. Mattson RH. Cramer JA. The choice of antiepileptic drugs in focal epilepsy. In: Wyllie E. ed. The treatment of epilepsy. Principles and practice. Philadelphia. London: Lea & Febiger. 1993:817-23.